Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KALINA M SANDERS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1487704953
CMS profile
158466
Location
JACKSONVILLE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$65,888.74

192 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KALINA M SANDERS

NPI 1487704953 · CMS profile ID 158466

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

JACKSONVILLE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1487704953?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KALINA M SANDERS, NPI 1487704953, CMS profile ID 158466. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1487704953?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). KALINA M SANDERS, NPI 1487704953, CMS profile ID 158466. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1487704953?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
KALINA M SANDERS, NPI 1487704953, CMS profile ID 158466, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1487704953?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

192 matching records · $65,888.74 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 192 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 192.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Teva Pharmaceuticals USA, Inc. $16.9609/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056701835 CMS
Biogen, Inc. $1.9609/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012194835 CMS
Biogen, Inc. $17.9909/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012231369 CMS
Neurocrine Biosciences, Inc. $24.9909/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052146425 CMS
Alexion Pharmaceuticals, Inc. $19.2209/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017019969 CMS
Celgene Corporation $600.0008/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451901 CMS
Otsuka America Pharmaceutical, Inc. $28.3108/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014780413 CMS
Biogen, Inc. $2,505.0008/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012182715 CMS
EMD Serono, Inc. $75.5708/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032373067 CMS
EMD Serono, Inc. $19.4908/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032375403 CMS
Mallinckrodt Hospital Products Inc. $14.4908/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042885981 CMS
EMD Serono, Inc. $14.1108/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032355055 CMS
TG Therapeutics, Inc. $19.9008/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051496873 CMS
SK Life Science, Inc. $30.4608/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054769713 CMS
Grifols USA, LLC $23.3108/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011853541 CMS
Biogen, Inc. $18.0008/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012231365 CMS
Lilly USA, LLC $16.3408/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031895973 CMS
EMD Serono, Inc. $16.7708/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032363809 CMS
Celgene Corporation $17.6508/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451789 CMS
Alexion Pharmaceuticals, Inc. $20.1007/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017057321 CMS
Lundbeck LLC $22.0307/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032345249 CMS
E.R. Squibb & Sons, L.L.C. $4,320.0007/26/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451719 CMS
Biogen, Inc. $25.6307/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012141247 CMS
Eisai Inc. $20.6407/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023317619 CMS
Genentech USA, Inc. $51.0407/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040420987 CMS
Genentech USA, Inc. $23.0607/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040420981 CMS
Otsuka America Pharmaceutical, Inc. $19.2107/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014780401 CMS
Biogen, Inc. $1,503.0007/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012237689 CMS
PFIZER INC. $24.5407/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050566343 CMS
Biogen, Inc. $17.4007/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012272185 CMS
EMD Serono, Inc. $11.8407/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032316709 CMS
GENZYME CORPORATION $147.4107/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050087995 CMS
AbbVie Inc. $5.5107/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998811783 CMS
Otsuka America Pharmaceutical, Inc. $24.3107/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014780392 CMS
EMD Serono, Inc. $9,520.0006/30/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052754347 CMS
EMD Serono, Inc. $23.1806/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032316701 CMS
Biogen, Inc. $0.3206/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012175055 CMS
Biogen, Inc. $16.3706/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012254997 CMS
Biogen, Inc. $4.7506/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012288777 CMS
Celgene Corporation $150.0006/26/2023 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061176494 CMS
AbbVie Inc. $25.0706/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998811777 CMS
Celgene Corporation $60.0006/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451725 CMS
Celgene Corporation $21.3306/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451729 CMS
Celgene Corporation $21.3306/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451735 CMS
Celgene Corporation $48.0006/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451741 CMS
Celgene Corporation $450.9906/24/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451747 CMS
Celgene Corporation $199.5506/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015451753 CMS
Sandoz Inc. $29.1506/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1028959039 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.9506/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055582315 CMS
Genentech USA, Inc. $4,520.0006/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040420965 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $130,494.57 238
PY2020 $33,082.37 132
PY2021 $84,484.06 206
PY2022 $101,027.60 205
PY2023 $65,888.74 192
PY2024 $76,082.51 200
PY2025 $53,110.49 181

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $50,439.99 14
PY2024 Principal investigator $26,274.53 32
PY2023 Principal investigator $89,485.80 23
PY2022 Principal investigator $113,595.90 13
PY2021 Principal investigator $47,588.00 4
PY2020 Principal investigator $6,400.00 4
PY2019 Principal investigator $10,048.00 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $101.00 12/22/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577048
Principal investigator 1 Genentech, Inc. $101.00 12/22/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577052
Principal investigator 1 Genentech, Inc. $41.00 12/22/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577057
Principal investigator 1 Genentech, Inc. $41.00 12/22/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577060
Principal investigator 1 Genentech, Inc. $13,068.00 10/17/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577044
Principal investigator 1 Genentech, Inc. $101.00 09/18/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577036
Principal investigator 1 Genentech, Inc. $3,754.20 09/17/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577039
Principal investigator 1 GENZYME CORPORATION $1,425.00 09/15/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc
A prospective, multicenter, observational, post-authorization safety study (PASS) to evaluate the long term safety profile of LEMTRADA (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis (RMS) No dispute reported 06/30/2026 1226138501
Principal investigator 1 GENZYME CORPORATION $1,425.00 08/04/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc
A prospective, multicenter, observational, post-authorization safety study (PASS) to evaluate the long term safety profile of LEMTRADA (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis (RMS) No dispute reported 06/30/2026 1226138480
Principal investigator 1 Genentech, Inc. $1,284.00 06/18/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577023
Principal investigator 1 Genentech, Inc. $387.00 06/18/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577027
Principal investigator 1 Genentech, Inc. $432.00 06/18/2025 Non-covered Recipient Entity
Baptist Health Ambulatory Services Inc.
Assessing disease activity in minority patients with relapsing multiple sclerosis using Ocrelizumab No dispute reported 06/30/2026 1211577032
Principal investigator 1 Novartis Pharmaceuticals Corporation $27,620.28 02/18/2025 Non-covered Recipient Entity
BAPTIST HEALTH RESEARCH INSTITUTE
A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament Light No dispute reported 06/30/2026 1190307825
Principal investigator 1 Novartis Pharmaceuticals Corporation $659.51 01/31/2025 Non-covered Recipient Entity
BAPTIST HEALTH RESEARCH INSTITUTE
A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament Light No dispute reported 06/30/2026 1190307823